SCI期刊点评
主页 > 学术交流 > SCI期刊点评 >

Current opinion in molecular therapeutics

2016-05-25来源:未知
NLM 缩写: Curr Opin Mol TherNLM ID: 100891485出版国家: England出版地: London出版商: Thomson Reuters (Scientific)...


 

NLM 缩写: Curr Opin Mol Ther
NLM ID: 100891485
出版国家: England
出版地: London
出版商: Thomson Reuters (Scientific) Ltd
出版周期: 双月刊
创刊年份: 1999
语言: 英语
SCI收录: YES
ISSN: 1464-8431 (印刷版)
2040-3445 (电子版)
1464-8431 (ISSNLinking)
PubMed收录: YES
研究领域: 药物设计、基因治疗、基因转移技术、合成疫苗

杂志简介/稿件收录要求
Published by Thomson Current Drugs. ISSN: 1464-8431.

Current Opinion in Molecular Therapeutics is designed to give you an overview of the most important developments across this field of research and saves you from having to hunt through the proliferation of scientific literature. Throughout the course of a year the journal highlights relevant progress made in gene therapy, vaccines, oligonucleotides, gene delivery systems, vectors, genomics and proteomics.

 

相关热词搜索:Currentopinionmolecular

分享到:

Copyright 深圳中洪博元生物科技有限公司 版权所有
邮箱:Zhby_6@163.com